276 related articles for article (PubMed ID: 26099277)
21. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
[TBL] [Abstract][Full Text] [Related]
22. Identification of the functional alteration signatures across different cancer types with support vector machine and feature analysis.
Wang S; Cai Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2218-2227. PubMed ID: 29277326
[TBL] [Abstract][Full Text] [Related]
23. Exploring the importance of cancer pathways by meta-analysis of differential protein expression networks in three different cancers.
Sikdar S; Datta S; Datta S
Biol Direct; 2016 Dec; 11(1):65. PubMed ID: 27993151
[TBL] [Abstract][Full Text] [Related]
24. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
[TBL] [Abstract][Full Text] [Related]
25. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
26. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
[TBL] [Abstract][Full Text] [Related]
27. A protein-centric approach for exome variant aggregation enables sensitive association analysis with clinical outcomes.
Li GXH; Munro D; Fermin D; Vogel C; Choi H
Hum Mutat; 2020 May; 41(5):934-945. PubMed ID: 31930623
[TBL] [Abstract][Full Text] [Related]
28. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
29. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
30. Network-based stratification of tumor mutations.
Hofree M; Shen JP; Carter H; Gross A; Ideker T
Nat Methods; 2013 Nov; 10(11):1108-15. PubMed ID: 24037242
[TBL] [Abstract][Full Text] [Related]
31. Discovery of mutated subnetworks associated with clinical data in cancer.
Vandin F; Clay P; Upfal E; Raphael BJ
Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
[TBL] [Abstract][Full Text] [Related]
32. Shared and unique mutational gene co-occurrences in cancers.
Liu J; Zhao D; Fan R
Biochem Biophys Res Commun; 2015 Oct; 465(4):777-83. PubMed ID: 26315265
[TBL] [Abstract][Full Text] [Related]
33. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
Chang WH; Forde D; Lai AG
Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
[TBL] [Abstract][Full Text] [Related]
34. Systematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes.
Fujimoto A; Okada Y; Boroevich KA; Tsunoda T; Taniguchi H; Nakagawa H
Sci Rep; 2016 May; 6():26483. PubMed ID: 27225414
[TBL] [Abstract][Full Text] [Related]
35. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
36. Computational approaches for the identification of cancer genes and pathways.
Dimitrakopoulos CM; Beerenwinkel N
Wiley Interdiscip Rev Syst Biol Med; 2017 Jan; 9(1):. PubMed ID: 27863091
[TBL] [Abstract][Full Text] [Related]
37. Passenger mutations accurately classify human tumors.
Salvadores M; Mas-Ponte D; Supek F
PLoS Comput Biol; 2019 Apr; 15(4):e1006953. PubMed ID: 30986244
[TBL] [Abstract][Full Text] [Related]
38. A computational approach for the discovery of significant cancer genes by weighted mutation and asymmetric spreading strength in networks.
Cutigi JF; Evangelista AF; Reis RM; Simao A
Sci Rep; 2021 Dec; 11(1):23551. PubMed ID: 34876593
[TBL] [Abstract][Full Text] [Related]
39. VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.
Jia P; Zhao Z
PLoS Comput Biol; 2014 Feb; 10(2):e1003460. PubMed ID: 24516372
[TBL] [Abstract][Full Text] [Related]
40. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT.
Gligorijević V; Malod-Dognin N; Pržulj N
Pac Symp Biocomput; 2016; 21():321-32. PubMed ID: 26776197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
